Grade My Investments
Home › Free Stock Grades › OSUR

OraSure Technologies, Inc. (OSUR) Stock Grade

OSUR · Healthcare

D+
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$272.0M
P/E Ratio
—
Revenue Growth (YoY)
-38.1%
Net Margin
-59.8%
Return on Equity
—
Dividend Yield
None

About OraSure Technologies, Inc.'s fundamentals

OraSure Technologies is a small-cap medical instruments and supplies company with a market capitalization of $272 million that is currently unprofitable, reporting a net loss in its latest annual statement with a net margin of -59.8%. The company is experiencing significant financial headwinds, with revenue declining 38.1% year-over-year, indicating a substantial contraction in sales. The absence of a dividend yield and the company's negative profitability metrics suggest OraSure is in a challenging operational period.

Track OSUR free — no credit card required. Live grade + monthly AI report →